
    
      Administration of standard single oral dose of sulfadoxine-pyrimethamine to children aged
      6-59 month old children in Lambaréné at enrolment, if eligible according to the approved
      protocol.

      139 subjects will be enrolled and treated with Sulfadoxine-Pyrimethamine for uncomplicated
      malaria. Thereafter each subject will be followed according to the approved protocol

      The proportion of subjects with Adequate Clinical and Parasitological response (ACPR) by day
      28, Early Treatment Failure (ETF), Late Clinical Failure (LCF) and Late Parasitological
      Failure (LPF)will be evaluated.

      secondly the frequency of molecular markers for Sulfadoxine-Pyrimethamine drug resistance
      will be determined.
    
  